Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)

References

• Lohman T, Bains G, Berk L, Lohman E. Predictors of biological age: the implications for wellness and aging research. Gerontol Geriatr Med. 2021;7:23337214211046419. doi:10.1177/23337214211046419
   Web of Science ®Google Scholar
• Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112–131.
   PubMed Web of Science ®Google Scholar
• Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49:359–367. doi:10.1016/j.molcel.2012.10.016
   PubMed Web of Science ®Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115
   PubMed Web of Science ®Google Scholar
• Perna L, Zhang Y, Mons U, Holleczek B, Saum K-U, Brenner H. Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics. 2016;8(1):64. doi:10.1186/s13148-016-0228-z
   PubMedGoogle Scholar
• Johnson LC, Parker K, Aguirre BF, et al. The plasma metabolome as a predictor of biological aging in humans. Geroscience. 2019;41:895–906. doi:10.1007/s11357-019-00123-w
   PubMed Web of Science ®Google Scholar
• Menni C, Kiddle SJ, Mangino M, et al. Circulating proteomic signatures of chronological age. J Gerontol a Biol Sci Med Sci. 2015;70:809–816. doi:10.1093/gerona/glu121
   PubMed Web of Science ®Google Scholar
• Rockwood K, Blodgett JM, Theou O, et al. A frailty index based on deficit accumulation quantifies mortality risk in humans and in mice. Sci Rep. 2017;7:43068. doi:10.1038/srep43068
   PubMed Web of Science ®Google Scholar
• Kim S, Jazwinski SM. Quantitative measures of healthy aging and biological age. Healthy Aging Res. 2015;4:26. doi:10.12715/har.2015.4.26
   PubMed Web of Science ®Google Scholar
• Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2018;15:e1002718. doi:10.1371/journal.pmed.1002718
   PubMedGoogle Scholar
• Waziry R, Gras L, Sedaghat S, et al. Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach. Eur J Epidemiol. 2019;34:793–799. doi:10.1007/s10654-019-00497-3
   PubMed Web of Science ®Google Scholar
• Muscari A, Bianchi G, Forti P, Magalotti D, Pandolfi P, Zoli M; Pianoro Study Group. N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people. Geroscience. 2021;43:845–857. doi:10.1007/s11357-020-00249-2
   PubMed Web of Science ®Google Scholar
• Muscari A, Bianchi G, Forti P, Magalotti D, Pandolfi P, Zolia M; Pianoro Study Group. The association of proBNPage with manifestations of age-related cardiovascular, physical and psychological impairment in community dwelling older adults. Geroscience. 2021;43:2087–2100. doi:10.1007/s11357-021-00381-7
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–663. doi:10.1056/NEJMoa031994
   PubMed Web of Science ®Google Scholar
• McKie PM, Rodeheffer RJ, Cataliotti A, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension. 2006;47:874–880.
   PubMed Web of Science ®Google Scholar
• Muscari A, Bianchi G, Forti P, et al. A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people--relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressure. Int J Clin Pract. 2013;67:1182–1191. doi:10.1111/ijcp.12195
   PubMed Web of Science ®Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–982. doi:10.1016/S0735-1097(02)02059-4
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254–258.
   PubMed Web of Science ®Google Scholar
• Luchner A, Behrens G, Stritzke J, et al. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors. Eur J Heart Fail. 2013;15:859–867. doi:10.1093/eurjhf/hft048
   PubMed Web of Science ®Google Scholar
• Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail. 2003;5:599–606. doi:10.1016/S1388-9842(03)00108-9
   PubMed Web of Science ®Google Scholar
• Crimmins EM, Thyagarajan B, Kim JK, Weir D, Faul J. Quest for a summary measure of biological age: the health and retirement study. Geroscience. 2021;43:395–408. doi:10.1007/s11357-021-00325-1
   PubMed Web of Science ®Google Scholar
• Aune D, Keum N, Giovannucci E, et al. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2018;108:1069–1091. doi:10.1093/ajcn/nqy097
   PubMed Web of Science ®Google Scholar
• Sadowska-Bartosz I, Bartosz G. Effect of antioxidants supplementation on aging and longevity. Biomed Res Int. 2014;2014:404680. doi:10.1155/2014/404680
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements and mortality. Curr Opin Clin Nutr Metab Care. 2014;17:40–41. doi:10.1097/MCO.0000000000000009
   PubMed Web of Science ®Google Scholar
• Aubert G. Telomere dynamics and aging. Prog Mol Biol Transl Sci. 2014;125:89–111.
   PubMed Web of Science ®Google Scholar
• Boccardi V, Paolisso G. Telomerase activation: a potential key modulator for human healthspan and longevity. Ageing Res Rev. 2014;15:1–5. doi:10.1016/j.arr.2013.12.006
   PubMed Web of Science ®Google Scholar
• Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr. 1986;116:641–654. doi:10.1093/jn/116.4.641
   PubMed Web of Science ®Google Scholar
• Weichhart T. mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology. 2018;64:127–134. doi:10.1159/000484629
   PubMed Web of Science ®Google Scholar
• Singh M, Jensen MD, Lerman A, et al. Effect of low-dose rapamycin on senescence markers and physical functioning in older adults with coronary artery disease: results of a pilot study. J Frailty Aging. 2016;5(4):204–207. doi:10.14283/jfa.2016.112
   PubMedGoogle Scholar
• Walters HE, Cox L. mTORC inhibitors as broad-spectrum therapeutics for age-related diseases. Int J Mol Sci. 2018;19:2325. doi:10.3390/ijms19082325
   PubMed Web of Science ®Google Scholar
• Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi:10.1136/bmj.e7586
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yuan KH. Practical Statistics Power Analysis Using Webpower and R. Granger, IN: ISDSA Press; 2018.
   Google Scholar
• Washburn RA, Smith KW, Jette AM, Janney CA. The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153–162. doi:10.1016/0895-4356(93)90053-4
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9
   PubMed Web of Science ®Google Scholar
• Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6(3):493–508. doi:10.2190/UURL-2RYU-WRYD-EY3K
   PubMed Web of Science ®Google Scholar
• Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186. doi:10.1093/geront/9.3_Part_1.179
   PubMed Web of Science ®Google Scholar
• Chan DC, Pang J, Watts GF. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10? Curr Atheroscler Rep. 2015;17:472. doi:10.1007/s11883-014-0472-7
   PubMed Web of Science ®Google Scholar
• Boccardi V, Barbieri M, Rizzo MR, et al. A new pleiotropic effect of statins in elderly: modulation of telomerase activity. FASEB J. 2013;27:3879–3885. doi:10.1096/fj.13-232066
   PubMed Web of Science ®Google Scholar
• Petrella RJ, Koval JJ, Cunningham DA, Paterson DH. A self-paced step test to predict aerobic fitness in older adults in the primary care clinic. J Am Geriatr Soc. 2001;49:632–638. doi:10.1046/j.1532-5415.2001.49124.x
   PubMed Web of Science ®Google Scholar
• Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013;167:1860–1866. doi:10.1016/j.ijcard.2012.04.156
   PubMed Web of Science ®Google Scholar
• Xia L, Wang XX, Hu XS, et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol. 2008;155:387–394. doi:10.1038/bjp.2008.272
   PubMed Web of Science ®Google Scholar
• Wang XB, Zhu L, Huang J, et al. Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin Med J. 2011;124:4310–4315.
   PubMed Web of Science ®Google Scholar
• Salvador L, Singaravelu G, Harley CB, Flom P, Suram A, Raffaele JM. A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo controlled study. Rejuvenation Res. 2016;19(6):478–484. doi:10.1089/rej.2015.1793
   PubMed Web of Science ®Google Scholar
• Savoia E, Fantini MP, Pandolfi PP, Dallolio L, Collina N. Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy. Health Qual Life Outcomes. 2006;4:47. doi:10.1186/1477-7525-4-47
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Kalén A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24:579–584. doi:10.1007/BF02535072
   PubMed Web of Science ®Google Scholar
• Mortensen SA, Rosenfeldt F, Kumar A, et al. Q-SYMBIO Study Investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2:641–649. doi:10.1016/j.jchf.2014.06.008
   PubMed Web of Science ®Google Scholar
• Fu X, Ji R, Dam J. Acute, subacute toxicity and genotoxic effect of Bio-Quinone Q10 in mice and rats. Regul Toxicol Pharmacol. 2009;53:1–5. doi:10.1016/j.yrtph.2008.09.003
   PubMed Web of Science ®Google Scholar
• Landbo C, Almdal TP. Interaktion mellem warfarin og coenzym Q10 [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger. 1998;160:3226–3227. Danish.
   PubMedGoogle Scholar
• Engelsen J, Nielsen JD, Hansen KF. Effekten af Coenzym Q10 og Ginkgo biloba på warfarindosis hos patienter i laengerevarende warfarinbehandling. Et randomiseret, dobbeltblindt, placebokontrolleret overkrydsningsforsøg [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger. 2003;165:1868–1871. Danish.
   PubMedGoogle Scholar
• Giovannini S, Onder G, Lattanzio F, et al. Selenium concentrations and mortality among community-dwelling older adults: results from IlSIRENTE study. J Nutr Health Aging. 2018;22:608–612. doi:10.1007/s12603-018-1021-9
   PubMed Web of Science ®Google Scholar
• Sun JW, Shu XO, Li HL, et al. Dietary selenium intake and mortality in two population-based cohort studies of 133 957 Chinese men and women. Public Health Nutr. 2016;19:2991–2998. doi:10.1017/S1368980016001130
   PubMed Web of Science ®Google Scholar
• Rayman MP, Winther KH, Pastor-Barriuso R, et al. Effect of long-term selenium supplementation on mortality: results from a multiple-dose, randomised controlled trial. Free Radic Biol Med. 2018;127:46–54. doi:10.1016/j.freeradbiomed.2018.02.015
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Abuaysheh S, et al. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab. 2010;95(9):E1–E8. doi:10.1210/jc.2010-0482
   PubMed Web of Science ®Google Scholar
• Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14:612–622. doi:10.1016/j.cmet.2011.10.002
   PubMed Web of Science ®Google Scholar
• Lam YY, Peterson CM, Ravussin E. Resveratrol vs. calorie restriction: data from rodents to humans. Exp Gerontol. 2013;48:1018–1024. doi:10.1016/j.exger.2013.04.005
   PubMed Web of Science ®Google Scholar
• Li YR, Li S, Lin CC. Effect of resveratrol and pterostilbene on aging and longevity. Biofactors. 2018;44:69–82. doi:10.1002/biof.1400
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010;70:9003–9011. doi:10.1158/0008-5472.CAN-10-2364
   PubMed Web of Science ®Google Scholar
• Hector KL, Lagisz M, Nakagawa S. The effect of resveratrol on longevity across species: a meta-analysis. Biol Lett. 2012;8(5):790–793. doi:10.1098/rsbl.2012.0316
   PubMed Web of Science ®Google Scholar
• Wang C, Wheeler CT, Alberico T, et al. The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age. 2013;35:69–81. doi:10.1007/s11357-011-9332-3
   PubMedGoogle Scholar
• Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342. doi:10.1038/nature05354
   PubMed Web of Science ®Google Scholar
• Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21:2084. doi:10.3390/ijms21062084
   PubMed Web of Science ®Google Scholar
• Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011;1215:9–15. doi:10.1111/j.1749-6632.2010.05842.x
   PubMed Web of Science ®Google Scholar
• Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. 2011;1215:161–169. doi:10.1111/j.1749-6632.2010.05853.x
   PubMed Web of Science ®Google Scholar
• Dow CT, Harley CB. Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study. Clin Ophthalmol. 2016;10:243–249. doi:10.2147/OPTH.S100042
   PubMed Web of Science ®Google Scholar
• Fernandez ML, Thomas MS, Lemos BS, et al. TA-65, A telomerase activator improves cardiovascular markers in patients with metabolic syndrome. Curr Pharm Des. 2018;24:1905–1911. doi:10.2174/1381612824666180316114832
   PubMed Web of Science ®Google Scholar
• Singaravelu G, Harley CB, Raffaele JM, Sudhakaran P, Suram A. Double blind, placebo controlled, randomized trial demonstrates telomerase activator TA-65 decreases immunosenescent CD8+CD28- T cells in humans. OBM Geriatrics. 2021;5:1. doi:10.21926/obm.geriatr.2102168
   Google Scholar